Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page gains new help/navigation sections (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study) and updates the revision tag from v3.5.5 to v3.6.0, with the Intervention/Treatment heading formatting adjusted.SummaryDifference0.3%

- Check15 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision tag updated to v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the page's metadata/versioning rather than its content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe webpage’s “Revision” label was updated from v3.5.2 to v3.5.3, indicating a minor technical version change without changing the underlying clinical trial content.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check93 days agoChange DetectedThe revision label on the page was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.